Mari Edlin

Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.

Biologic medicines could lower spending by $153 billion by 2023.

FDA plans to finalize the draft in 2019. 

Changes fueled by the 2003 Medicare Prescription Drug Improvement and Modernization Act.

Programs increasingly cater to the uninsured and underinsured

What needs to be considered before independent and chain pharmacies branch into the specialty arena. 

Pharmacists are urged to adopt protocols to combat the constant rise of antibiotic resistance.